[go: up one dir, main page]

US20080248145A1 - Composition for a Feeling of Calmness - Google Patents

Composition for a Feeling of Calmness Download PDF

Info

Publication number
US20080248145A1
US20080248145A1 US12/060,329 US6032908A US2008248145A1 US 20080248145 A1 US20080248145 A1 US 20080248145A1 US 6032908 A US6032908 A US 6032908A US 2008248145 A1 US2008248145 A1 US 2008248145A1
Authority
US
United States
Prior art keywords
composition
individual
sleep
extract
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/060,329
Inventor
Marvin Heuer
Ken Clement
Shan Chaudhuri
Megan Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iomedix Development International SRL
Original Assignee
Iomedix Development International SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iomedix Development International SRL filed Critical Iomedix Development International SRL
Priority to US12/060,329 priority Critical patent/US20080248145A1/en
Assigned to IOMEDIX DEVELOPMENT INTERNATIONAL SRL reassignment IOMEDIX DEVELOPMENT INTERNATIONAL SRL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHAUDHURI, SHAN, CLEMENT, KEN, THOMAS, MEGAN, HEUER, MARVIN, DR
Publication of US20080248145A1 publication Critical patent/US20080248145A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3486Humulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian

Definitions

  • the present invention is directed towards supplemental compositions and methods for promoting restful sleep in an individual by producing a feeling of calmness.
  • Sleep occupies about one-third of our life and is necessary for mental and physical well-being. It additionally affects mood, behavior and physiology. Sleep and the control of sleep is a complex process involving multiple neuro-chemical pathways and associated brain structures. It is a dynamic process involving a shift in the balance of distinct physiological changes, involving both positive and negative signaling neural signaling.
  • the regulation of sleep in humans is governed by three processes—each influenced by hormonal and environmental factors: a daily sleep-wake cycle influenced by a circadian rhythm (24 hour cycle) tied to light-dark cycles.
  • insomnia is estimated to affect a significant portion of the population every year and is associated with health problems and concomitant economic losses to society (Stoller M K. Economic effects of insomnia. Clin Ther. 1994 September-October; 16(5):873-97 Abstract). It is clear that the impairment of sleep is detrimental to one's health. In humans, mild sleep deprivation results in indications of impaired immune system function (Irwin M, McClintick J, Costlow C, Fortner M, White J, Gillin J C. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 1996 April; 10(5):643-53). Prolonged sleep deprivation is even known to result in death. It has been determined by many that an individual can survive longer without food than one can without sleep; thus indicating the importance of sleep.
  • the present invention is directed towards a composition for promoting feeling of calmness in an individual comprising and extract of Hops, Eclipta alba powder, and Nardostachys jatamansi .
  • a method for promoting a restful period of sleep via an induction of a calming feeling in an individual comprising the step of administration of, to an individual, a composition comprising Hops, Eclipta alba powder, and Nardostachys jatamansi to produce a feeling of calmness.
  • sheep for the purposes of the present invention is defined as a natural or artificially induced state of suspension of sensory and motor activity in an individual.
  • improvements in sleep may be both of a quantitative nature e.g. an increase in the length of sleep, a decreased in the time of sleep onset, and of a qualitative nature e.g. a deeper, more restful undisturbed period of sleep. It is further understood that improvements in sleep may also be both direct and indirect. For example, sleep will be directly improved by the administration of a substance which is known to reduce the time to sleep onset. Sleep may be indirectly improved, for example, by the administration of a substance which is known to result in feelings of relaxation and calmness. It is an aspect of the present invention to provide an individual consuming a composition of the present invention herein disclosed with an induced feeling of calmness, thus leading to improved sleep.
  • the Hop plant ( Humulus lupulus ) is a flowering vine used traditionally as a sedative for anxiety and sleep difficulties.
  • Hops extract has been shown to have sleep-enhancing and antidepressant activities (Zanoli P, Rivasi M, Zavatti M, Brusiani F, Baraldi M. New insight in the neuropharmacological activity of Humulus lupulus L. J Ethnopharmacol. 2005 Oct. 31; 102(1):102-6).
  • administration of Hops extract has been shown to produce sedative effects (Schiller H, Forster A, Vonhoff C, Hegger M, Biller A, Winterhoff H. Related Sedating effects of Humulus lupulus L. extracts. Phytomedicine.
  • Hops extract has been shown to modulate the gamma-aminobutyric acid receptor (GABA(A) receptors) and display GABA-like activity (Aoshima H, Takeda K, Okita Y, Hossain S J, Koda H, Kiso Y. Effects of beer and hop on ionotropic gamma-aminobutyric acid receptors. J Agric Food Chem. 2006 Apr. 5; 54(7):2514-9); the mechanism at least in part responsible for the aforementioned effects.
  • GABA is an inhibitory neurotransmitter that can induce relaxation and sleep. Modulation of any or all of these receptors may mediate the sleep-inducing activity of Hops.
  • the composition comprises an extract of Hops to promote a feeling of calmness and sedation through modulation of GABA-signaling.
  • a serving of the supplemental composition comprises from about 0.001 g to about 0.500 g of an extract of Hops.
  • the preferred dosage of an extract of Hops in the present invention comprises about 0.120 g. per serving.
  • Eclipta alba plant grows as a weed in Asia and South America. It has been used in traditional medicine for many treatments. Eclipta alba extract has been shown to possess nootropic effects and attenuate stress-induced neurochemical changes in animal studies (Thakur V D, Mengi S A. Neuropharmacological profile of Eclipta alba (Linn.) Hassk. J. Ethnopharmacol. 2005 Oct. 31; 102(1):23-31 Abstract) as well as have analgesic effects (Sawant M, Isaac J C, Narayanan S. Analgesic studies on total alkaloids and alcohol extracts of Eclipta alba (Linn.) Hassk. Phytother Res. 2004 February; 18(2):111-3 Abstract).
  • the composition comprises Eclipta alba powder to reduce the effects of stress conducive to a feeling of calmness.
  • a serving of the supplemental composition comprises from about 0.001 g to about 0.100 g of Eclipta alba powder.
  • the preferred dosage of Eclipta alba powder in the present invention comprises about 0.005 g per serving.
  • Nardostachys jatamansi herb is part of traditional Indian medicine where it is used for treatments affecting the central nervous system, particularly for depressant action (Joshi H, Parle M. Nardostachys jatamansi improves learning and memory in mice. J Med Food. 2006 Spring; 9(1):113-8).
  • the effect of acute and subchronic administration of an extract of the roots of Nardostachys jatamansi has been shown to significantly increase serotonin (5-HT) in Wistar rats.
  • Serotonin is a neurochemical, concentrated in the raphe nucleus region of the brain wherein its axon project into several areas of the brain such as the hypothalamus. Through its resultant actions on the hypothalamus, serotonin is understood to be involved in inducing sleep and control of mood, among other function.
  • many well-known antidepressants act by inducing serotonin release or inhibiting its re-uptake in the brains. It is herein understood by the inventors that increasing the amount of serotonin is beneficial to induce sleep and promote a feeling of calmness in an individual.
  • the composition comprises Nardostachys jatamansi to aid in promoting a feeling of calmness, an good mood and induce sleep in an individual following administration.
  • a serving of the supplemental composition comprises from about 0.001 g to about 0.100 g of Nardostachys jatamansi extract.
  • the preferred dosage of Nardostachys jatamansi extract in the present invention comprises about 0.020 g per serving.
  • the composition comprises an extract of Hops, Eclipta alba powder, and Nardostachys jatamansi for the promotion of a restful period of sleep in an individual by producing a feeling of calmness.
  • the components of the present invention will act in concert through distinct mechanisms to promote a restful period of sleep by producing a feeling of calmness which will be conducive to the onset of sleep.
  • the nutritional supplement may be consumed in any form.
  • the dosage form of the nutritional supplement may be provided as, e.g., a powder beverage mix, a liquid beverage, a ready-to-eat bar or drink product, a capsule, a liquid capsule, a tablet, a caplet, or as a dietary gel.
  • the preferred dosage forms of the present invention are as a tablet or caplet.
  • the composition may be provided in a solid dosage form with specific controlled release characteristics.
  • the composition may be provided in a layered solid dosage form.
  • each individual layer will provide unique dissolution characteristics. In this way a controlled release of the composition can be achieved.
  • each layer may contain a homogeneous mixture of ingredients whereby the release of the ingredients is dependent upon the characteristics of layer to which the ingredients are included.
  • each layer may contain a distinct set of specific ingredients which differ according to the layer such that different specific ingredients are released at different times. In all aspects of this embodiment, a temporally controlled release of ingredients is achieved.
  • the dosage form of the nutritional supplement may be provided in accordance with customary processing techniques for herbal and nutritional supplements in any of the forms mentioned above.
  • the nutritional supplement set forth in the example embodiment herein may contain any appropriate number and type of excipients, as is well known in the art.
  • the present nutritional composition or those similarly envisioned by one of skill in the art may be utilized in methods to promote and support a restful period of sleep in an individual.
  • a method for the promotion of restful sleep in an individual through inducing a feeling of calmness in an individual is provided.
  • the method of the present invention comprises at least the step of administering to an individual a therapeutically acceptable amount of the composition of the present invention.
  • the present composition may be used not only as a sole means of promoting and supporting restful sleep but may also be used either in addition to other similarly-directed compositions or as a component of a larger composition.
  • a nutritional supplement to help promote restful, quality sleep for use immediately prior to bedtime is provided in the following the composition.
  • a serving of the nutritional supplement as a caplet contains the following ingredients:

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for promoting restful, quality sleep in an individual comprising the administration of a composition comprising Hops extract, Eclipta alba extract powder, and Nardostachys jatamansi extract.

Description

    RELATED APPLICATION
  • This application is a continuation of U.S. application Ser. No. 11/696,945, filed Apr. 4, 2007 and claims benefit of priority thereto.
  • FIELD OF THE INVENTION
  • The present invention is directed towards supplemental compositions and methods for promoting restful sleep in an individual by producing a feeling of calmness.
  • BACKGROUND OF THE INVENTION
  • Sleep occupies about one-third of our life and is necessary for mental and physical well-being. It additionally affects mood, behavior and physiology. Sleep and the control of sleep is a complex process involving multiple neuro-chemical pathways and associated brain structures. It is a dynamic process involving a shift in the balance of distinct physiological changes, involving both positive and negative signaling neural signaling. The regulation of sleep in humans is governed by three processes—each influenced by hormonal and environmental factors: a daily sleep-wake cycle influenced by a circadian rhythm (24 hour cycle) tied to light-dark cycles.
  • The need for sleep is a biological drive similar to thirst or hunger. Interestingly though, the function of sleep is largely unknown, however some evidence indicates that sleep is required for learning. In North America, insomnia is estimated to affect a significant portion of the population every year and is associated with health problems and concomitant economic losses to society (Stoller M K. Economic effects of insomnia. Clin Ther. 1994 September-October; 16(5):873-97 Abstract). It is clear that the impairment of sleep is detrimental to one's health. In humans, mild sleep deprivation results in indications of impaired immune system function (Irwin M, McClintick J, Costlow C, Fortner M, White J, Gillin J C. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 1996 April; 10(5):643-53). Prolonged sleep deprivation is even known to result in death. It has been determined by many that an individual can survive longer without food than one can without sleep; thus indicating the importance of sleep.
  • Strategies to improve sleep are beneficial, not only in terms of one's physical health, but also in terms of emotional health. Furthermore, reinforcement of sleep of adequate quantity and quality positively impacts most aspect of daily life.
  • SUMMARY OF THE INVENTION
  • The foregoing needs and other needs and objectives that will become apparent for the following description are achieved in the present invention, which comprises an extract of Hops, Eclipta alba powder, and Nardostachys jatamansi for the promotion of restful sleep in an individual by producing a feeling of calmness.
  • DETAILED DESCRIPTION OF THE INVENTION
  • In the following description, for the purposes of explanations, numerous specific details are set forth in order to provide a thorough understanding of the present invention. It will be apparent, however, to one of ordinary skill in the art that the present invention may be practiced without these specific details.
  • The present invention is directed towards a composition for promoting feeling of calmness in an individual comprising and extract of Hops, Eclipta alba powder, and Nardostachys jatamansi. A method for promoting a restful period of sleep via an induction of a calming feeling in an individual is also provided comprising the step of administration of, to an individual, a composition comprising Hops, Eclipta alba powder, and Nardostachys jatamansi to produce a feeling of calmness.
  • The term ‘sleep’ for the purposes of the present invention is defined as a natural or artificially induced state of suspension of sensory and motor activity in an individual.
  • It is herein understood that improvements in sleep may be both of a quantitative nature e.g. an increase in the length of sleep, a decreased in the time of sleep onset, and of a qualitative nature e.g. a deeper, more restful undisturbed period of sleep. It is further understood that improvements in sleep may also be both direct and indirect. For example, sleep will be directly improved by the administration of a substance which is known to reduce the time to sleep onset. Sleep may be indirectly improved, for example, by the administration of a substance which is known to result in feelings of relaxation and calmness. It is an aspect of the present invention to provide an individual consuming a composition of the present invention herein disclosed with an induced feeling of calmness, thus leading to improved sleep.
  • Hops (Humulus lupulus)
  • The Hop plant (Humulus lupulus) is a flowering vine used traditionally as a sedative for anxiety and sleep difficulties. In mice, Hops extract has been shown to have sleep-enhancing and antidepressant activities (Zanoli P, Rivasi M, Zavatti M, Brusiani F, Baraldi M. New insight in the neuropharmacological activity of Humulus lupulus L. J Ethnopharmacol. 2005 Oct. 31; 102(1):102-6). Additionally, in rats, administration of Hops extract has been shown to produce sedative effects (Schiller H, Forster A, Vonhoff C, Hegger M, Biller A, Winterhoff H. Related Sedating effects of Humulus lupulus L. extracts. Phytomedicine. 2006 September; 13(8):535-41 Abstract). Hops extract has been shown to modulate the gamma-aminobutyric acid receptor (GABA(A) receptors) and display GABA-like activity (Aoshima H, Takeda K, Okita Y, Hossain S J, Koda H, Kiso Y. Effects of beer and hop on ionotropic gamma-aminobutyric acid receptors. J Agric Food Chem. 2006 Apr. 5; 54(7):2514-9); the mechanism at least in part responsible for the aforementioned effects. GABA is an inhibitory neurotransmitter that can induce relaxation and sleep. Modulation of any or all of these receptors may mediate the sleep-inducing activity of Hops.
  • In an embodiment of the present invention which is set forth in greater detail in the example below, the composition comprises an extract of Hops to promote a feeling of calmness and sedation through modulation of GABA-signaling. A serving of the supplemental composition comprises from about 0.001 g to about 0.500 g of an extract of Hops. The preferred dosage of an extract of Hops in the present invention comprises about 0.120 g. per serving.
  • Eclipta alba
  • The Eclipta alba plant grows as a weed in Asia and South America. It has been used in traditional medicine for many treatments. Eclipta alba extract has been shown to possess nootropic effects and attenuate stress-induced neurochemical changes in animal studies (Thakur V D, Mengi S A. Neuropharmacological profile of Eclipta alba (Linn.) Hassk. J. Ethnopharmacol. 2005 Oct. 31; 102(1):23-31 Abstract) as well as have analgesic effects (Sawant M, Isaac J C, Narayanan S. Analgesic studies on total alkaloids and alcohol extracts of Eclipta alba (Linn.) Hassk. Phytother Res. 2004 February; 18(2):111-3 Abstract).
  • In an embodiment of the present invention which is set forth in greater detail in the example below, the composition comprises Eclipta alba powder to reduce the effects of stress conducive to a feeling of calmness. A serving of the supplemental composition comprises from about 0.001 g to about 0.100 g of Eclipta alba powder. The preferred dosage of Eclipta alba powder in the present invention comprises about 0.005 g per serving.
  • Nardostachys jatamansi
  • Nardostachys jatamansi herb is part of traditional Indian medicine where it is used for treatments affecting the central nervous system, particularly for depressant action (Joshi H, Parle M. Nardostachys jatamansi improves learning and memory in mice. J Med Food. 2006 Spring; 9(1):113-8). The effect of acute and subchronic administration of an extract of the roots of Nardostachys jatamansi has been shown to significantly increase serotonin (5-HT) in Wistar rats. In these experiments, however the levels of other neurochemicals such as norepinephrine and dopamine remained unchanged (Prabhu V, Karanth K S, Rao A Effects of Nardostachys jatamansi on biogenic amines and inhibitory amino acids in the rat brain. Planta Med. 1994 April; 60(2):114-7 (Abstract)). Serotonin is a neurochemical, concentrated in the raphe nucleus region of the brain wherein its axon project into several areas of the brain such as the hypothalamus. Through its resultant actions on the hypothalamus, serotonin is understood to be involved in inducing sleep and control of mood, among other function. In fact, many well-known antidepressants act by inducing serotonin release or inhibiting its re-uptake in the brains. It is herein understood by the inventors that increasing the amount of serotonin is beneficial to induce sleep and promote a feeling of calmness in an individual.
  • In an embodiment of the present invention which is set forth in greater detail in the example below, the composition comprises Nardostachys jatamansi to aid in promoting a feeling of calmness, an good mood and induce sleep in an individual following administration. A serving of the supplemental composition comprises from about 0.001 g to about 0.100 g of Nardostachys jatamansi extract. The preferred dosage of Nardostachys jatamansi extract in the present invention comprises about 0.020 g per serving.
  • In a preferred embodiment of the present invention, the composition comprises an extract of Hops, Eclipta alba powder, and Nardostachys jatamansi for the promotion of a restful period of sleep in an individual by producing a feeling of calmness.
  • Not wishing to be bound by theory, it is believed that the components of the present invention will act in concert through distinct mechanisms to promote a restful period of sleep by producing a feeling of calmness which will be conducive to the onset of sleep.
  • According to various embodiments of the present invention, the nutritional supplement may be consumed in any form. For instance, the dosage form of the nutritional supplement may be provided as, e.g., a powder beverage mix, a liquid beverage, a ready-to-eat bar or drink product, a capsule, a liquid capsule, a tablet, a caplet, or as a dietary gel. The preferred dosage forms of the present invention are as a tablet or caplet.
  • In an embodiment of the present invention the composition may be provided in a solid dosage form with specific controlled release characteristics. Advantageously, the composition may be provided in a layered solid dosage form. In such a form each individual layer will provide unique dissolution characteristics. In this way a controlled release of the composition can be achieved. In one aspect of this embodiment, each layer may contain a homogeneous mixture of ingredients whereby the release of the ingredients is dependent upon the characteristics of layer to which the ingredients are included. In an alternative aspect of this embodiment, each layer may contain a distinct set of specific ingredients which differ according to the layer such that different specific ingredients are released at different times. In all aspects of this embodiment, a temporally controlled release of ingredients is achieved.
  • Furthermore, the dosage form of the nutritional supplement may be provided in accordance with customary processing techniques for herbal and nutritional supplements in any of the forms mentioned above. Additionally, the nutritional supplement set forth in the example embodiment herein may contain any appropriate number and type of excipients, as is well known in the art.
  • The present nutritional composition or those similarly envisioned by one of skill in the art may be utilized in methods to promote and support a restful period of sleep in an individual. By way of ingestion of the composition of the present invention, a method for the promotion of restful sleep in an individual through inducing a feeling of calmness in an individual is provided. The method of the present invention comprises at least the step of administering to an individual a therapeutically acceptable amount of the composition of the present invention.
  • Advantageously, the present composition may be used not only as a sole means of promoting and supporting restful sleep but may also be used either in addition to other similarly-directed compositions or as a component of a larger composition.
  • Although the following example illustrates the practice of the present invention in one of its embodiments, the example should not be construed as limiting the scope of the invention. Other embodiments will be apparent to one of skill in the art from consideration of the specifications and example.
  • EXAMPLE
  • A nutritional supplement to help promote restful, quality sleep for use immediately prior to bedtime is provided in the following the composition. A serving of the nutritional supplement as a caplet contains the following ingredients:
      • About 0.120 g of an extract of Hops, about 0.005 g of, about 0.005 g of Eclipta alba powder, and about 0.020 g of Nardostachys jatamansi.
    EXTENSIONS AND ALTERNATIVES
  • In the foregoing specification, the invention has been described with a specific embodiment thereof, however, it will be evident that various modifications and changes may be made thereto without departing from the broader spirit and scope of the invention.

Claims (8)

1. A composition comprising an effective amount of an extract of Hops, an effective amount of Eclipta alba powder, and an effective amount of Nardostachys jatamansi.
2. The composition of claim 1 wherein the composition is provided in a therapeutically effective amount to synergistically induce sedation in an individual upon administration to said individual
3. The composition of claim 1 wherein the composition is provided in a therapeutically effective amount to synergistically induce a feeling of calm in an individual upon administration to said individual.
4. A method of promoting restful sleep in an individual comprising the step of administering to the individual a composition comprising an effective amount of an Hops extract, an effective amount of Eclipta alba extract powder, and an effective amount of Nardostachys jatamansi extract.
5. The method of claim 4 wherein the administration of the composition is effective to synergistically induces sedation in said individual.
6. the method the claim 4 wherein the administration of the composition synergistically induces a feeling of calm in said individual.
7. The composition of claim 1, wherein the composition is in a specifically controlled release solid dosage form.
8. The method of claim 4, wherein the composition is in a specifically controlled release solid dosage form.
US12/060,329 2007-04-05 2008-04-01 Composition for a Feeling of Calmness Abandoned US20080248145A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/060,329 US20080248145A1 (en) 2007-04-05 2008-04-01 Composition for a Feeling of Calmness

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/696,945 US7374785B1 (en) 2007-04-05 2007-04-05 Composition for a feeling of calmness
US12/060,329 US20080248145A1 (en) 2007-04-05 2008-04-01 Composition for a Feeling of Calmness

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/696,945 Continuation US7374785B1 (en) 2007-04-05 2007-04-05 Composition for a feeling of calmness

Publications (1)

Publication Number Publication Date
US20080248145A1 true US20080248145A1 (en) 2008-10-09

Family

ID=39387560

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/696,945 Active US7374785B1 (en) 2007-04-05 2007-04-05 Composition for a feeling of calmness
US12/060,329 Abandoned US20080248145A1 (en) 2007-04-05 2008-04-01 Composition for a Feeling of Calmness

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/696,945 Active US7374785B1 (en) 2007-04-05 2007-04-05 Composition for a feeling of calmness

Country Status (1)

Country Link
US (2) US7374785B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240000716A1 (en) * 2018-02-16 2024-01-04 The New Zealand Institute For Plant And Food Research Limited Oral Dosage Forms Comprising a Hops Extract
US12213505B2 (en) 2021-07-05 2025-02-04 Healthy Ingredient Solutions, LLC Composition for promoting restful sleep and methods of making and using the same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017072798A1 (en) * 2015-10-30 2017-05-04 Nisarga Biotech Private Limited Therapeutic compositions comprising herbal extracts and essential oils for smoking and vaporization

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770207A (en) * 1997-03-17 1998-06-23 Natrol, Incorporated Dietary supplements containing kava root extract, passion flower, chamomile flowers, hops, and schizandra fruit
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU946544A1 (en) * 1980-03-25 1982-07-30 Харьковская Парфюмерно-Косметическая Фабрика Shampoo for washing hair
JP2003183135A (en) * 2001-12-21 2003-07-03 Kanoko Nishigori Shampoo

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770207A (en) * 1997-03-17 1998-06-23 Natrol, Incorporated Dietary supplements containing kava root extract, passion flower, chamomile flowers, hops, and schizandra fruit
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240000716A1 (en) * 2018-02-16 2024-01-04 The New Zealand Institute For Plant And Food Research Limited Oral Dosage Forms Comprising a Hops Extract
US12246095B2 (en) * 2018-02-16 2025-03-11 The New Zealand Institute For Plant And Food Research Limited Oral dosage forms comprising a hops extract
US12213505B2 (en) 2021-07-05 2025-02-04 Healthy Ingredient Solutions, LLC Composition for promoting restful sleep and methods of making and using the same

Also Published As

Publication number Publication date
US7374785B1 (en) 2008-05-20

Similar Documents

Publication Publication Date Title
US7455864B2 (en) Melatonin-based composition for improved sleep
Rowland et al. A review of plant-derived and herbal approaches to the treatment of sexual dysfunctions
US20080254121A1 (en) Multi-layer melatonin composition
Chen et al. A study of antidepressant effect and mechanism on intranasal delivery of BDNF-HA2TAT/AAV to rats with post-stroke depression
Mohebbati et al. Protective effects of long-term administration of Ziziphus jujuba fruit extract on cardiovascular responses in L-NAME hypertensive rats
Feizi et al. Medicinal plants for management of insomnia: A systematic review of animal and human studies
Maliki et al. Salvia officinalis and Lippia triphylla: Chemical characterization and evaluation of antidepressant-like activity
Zhu et al. Dendrobium officinale flos increases neurotrophic factor expression in the hippocampus of chronic unpredictable mild stress‐exposed mice and in astrocyte primary culture and potentiates NGF‐induced neuronal differentiation in PC12 cells
US7374785B1 (en) Composition for a feeling of calmness
Saikia et al. Erectile dysfunction: basics and its management using plant products
Zhang et al. Research progress in the effect of traditional Chinese medicine for invigoration on neurotransmitter related diseases
Singh Neuropharmacological aspects of Crocus sativus L.: a review of preclinical studies and ongoing clinical research
EP4366730A1 (en) Composition for promoting restful sleep and methods of making and using the same
El-Khatib et al. Over-the-Counter Supplements and Men's Health
WO2008122101A1 (en) Composition for promoting sleep and calmness comprising an extract of hops, eclipta alba and nordostachys jatamansi
US20080248141A1 (en) Composition for a feeling of relaxation
KR101291338B1 (en) Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress
WO2008122099A1 (en) Composition for promoting sleep and relaxation comprising lemon balm
Kaur et al. Antihypertensive Drugs-Ayurvedic Perspective
Hojati The Combined Effects of Saffron (Crocus sativus L.) and Exercise on Body Health: A Review Study.
Salama et al. Naringin Attenuates D-galactose-Induced Brain Aging Via Regulation Of Oxidative Stress Markers TNF-α, NF-κβ And Modulation Of The Neurotrophic Markers PGC1-α, NT-3 AGEs, And GFAP In Vivo
Yavuz et al. Herbs potentially enhancing sports performance.
Gupta et al. Emerging mechanisms and potential antidepressant action of medicinal plants
WO2008122102A1 (en) Melatonin-based composition for improved sleep
JP6989976B2 (en) Composition for improving cognitive function containing whale extract as an active ingredient

Legal Events

Date Code Title Description
AS Assignment

Owner name: IOMEDIX DEVELOPMENT INTERNATIONAL SRL, BARBADOS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HEUER, MARVIN, DR;CLEMENT, KEN;CHAUDHURI, SHAN;AND OTHERS;REEL/FRAME:020734/0215;SIGNING DATES FROM 20070425 TO 20070427

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION